Clinical trial
Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast…
NCT00075673 · Case Comprehensive Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00075673 |
|---|---|
| Title | Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer |
| Official title | A Phase I Study of Weekly Administration of Oral Navelbine in Combination With the COX-2 Inhibitor Celebrex in Relapsed and/or Metastatic Breast Cancer |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | celecoxib, vinorelbine ditartrate |
| Enrollment | 6 |
| Start date | Nov 1, 2003 |
| Primary completion | Sep 1, 2004 |
| Completion | Feb 1, 2005 |
| First posted | Jan 12, 2004 |
| Last update posted | Jul 27, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: